News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Oliviero James F III
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 250,000 shares
@ $0 |
|
| 03/03/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 5,548 shares
@ $4.65, valued at
$25.8k
Granted 15,000 shares
@ $0
Sold 5,483 shares
@ $5, valued at
$27.4k
|
|
| 02/03/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 10,261 shares
@ $4.77, valued at
$48.9k
|
|
| 01/12/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 3,817 shares
@ $6.749, valued at
$25.8k
|
|
| 01/12/2023 |
5
| Oliviero James F III (CEO, President and Director) has filed a Form 5 on Checkpoint Therapeutics, Inc. |
| 07/01/2022 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 228,000 shares
@ $1.09, valued at
$248.5k
Sold 21,000 shares
@ $1.09, valued at
$22.9k
Sold 12,000 shares
@ $1.09, valued at
$13.1k
Sold 15,000 shares
@ $1.11, valued at
$16.7k
|
|
| 04/22/2022 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 302,777 shares
@ $3.11, valued at
$941.6k
Paid exercise price by delivering 53,024 shares
@ $2.77, valued at
$146.9k
Paid exercise price by delivering 143,136 shares
@ $2.19, valued at
$313.5k
Paid exercise price by delivering 31,972 shares
@ $2.46, valued at
$78.7k
Paid exercise price by delivering 117,657 shares
@ $1.85, valued at
$217.7k
Sold 86,353 shares
@ $1.79, valued at
$154.6k
Sold 14,030 shares
@ $1.77, valued at
$24.8k
Sold 21,258 shares
@ $1.51, valued at
$32.1k
|
|
| 04/05/2022 |
4
| Oliviero James F III (Director) has filed a Form 4 on Nuvectis Pharma, Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.02, valued at
$105.3k
|
|
| 02/08/2022 |
3
| Oliviero James F III (Director) has filed a Form 3 on Nuvectis Pharma, Inc. |
| 02/02/2022 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 455,000 shares
@ $0 |
|
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 485,000 shares
@ $0 |
|
| 02/01/2018 |
4
| Oliviero James F III (CEO and President) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 325,000 shares
@ $0 |
|
| 12/19/2016 |
4
| Oliviero James F III (CEO and President) has filed a Form 4 on Checkpoint Therapeutics, Inc. |
| 10/04/2016 |
3
| Oliviero James F III (CEO and President) has filed a Form 3 on Checkpoint Therapeutics, Inc. |
| 07/08/2015 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,943 shares
@ $9.61, valued at
$18.7k
|
|
| 05/12/2015 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Exercised 18,333 options to buy
@ $2.53, valued at
$46.4k
Exercised 23,278 options to buy
@ $2.78, valued at
$64.7k
|
|
| 04/08/2015 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,878 shares
@ $11.68, valued at
$21.9k
|
|
| 01/06/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/12/2014 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Exercised 25,000 shares
@ $11.22, valued at
$280.5k
Sold 25,000 shares
@ $15.69, valued at
$392.3k
|
|
| 10/07/2014 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,694 shares
@ $16.14, valued at
$43.5k
|
|
| 09/10/2014 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 144,237 shares
@ $15.88, valued at
$2.3M
|
|
| 07/09/2014 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,054 shares
@ $15.75, valued at
$32.4k
|
|
| 04/07/2014 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,087 shares
@ $16.46, valued at
$34.4k
|
|
| 03/21/2014 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Exercised 36,667 shares
@ $2.53, valued at
$92.8k
Exercised 18,622 shares
@ $2.78, valued at
$51.8k
Exercised 48,750 shares
@ $4.58, valued at
$223.3k
Sold 154,039 shares
@ $15.23, valued at
$2.3M
Sold 125,000 shares
@ $15.04, valued at
$1.9M
Sold 13,444 shares
@ $15.11, valued at
$203.1k
|
|
| 01/06/2014 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 22,741 shares
@ $0
Sold 6,309 shares
@ $12.57, valued at
$79.3k
Granted 53,062 options to buy
@ $12.63, valued at
$670.2k
|
|
| 12/31/2013 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 30,000 shares
@ $12.68, valued at
$380.4k
Sold 49,500 shares
@ $12.62, valued at
$624.7k
Exercised 30,000 shares
@ $4.59, valued at
$137.7k
Sold 30,000 shares
@ $12.64, valued at
$379.2k
|
|
| 10/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2013 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 33,520 shares
@ $0
Sold 10,859 shares
@ $2.74, valued at
$29.8k
Granted 55,866 options to buy
@ $2.78, valued at
$155.3k
|
|
| 10/05/2012 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 4,973 shares
@ $2.72, valued at
$13.5k
|
|
| 07/06/2012 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 4,559 shares
@ $1.99, valued at
$9.1k
|
|
| 05/22/2012 |
4
| Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 400,000 shares
@ $0 |
|
|
|
|